Core Viewpoint - Huali Chuangtong's stock price has shown fluctuations with a recent increase of 2.27%, while the company has experienced a year-to-date stock price increase of 8.04% [1][2] Financial Performance - For the period from January to September 2025, Huali Chuangtong achieved a revenue of 564 million yuan, representing a year-on-year growth of 26.32%, and a net profit attributable to shareholders of 9.39 million yuan, which is a significant increase of 132.60% [2] - Cumulative cash dividends since the company's A-share listing amount to 97.81 million yuan, with no dividends distributed in the past three years [3] Stock Market Activity - As of November 20, Huali Chuangtong's stock was trading at 22.57 yuan per share, with a total market capitalization of 14.957 billion yuan [1] - The stock has seen a trading volume of 1.06 billion yuan, with a turnover rate of 0.92% [1] - The company has experienced a net outflow of 12.42 million yuan in principal funds, with significant selling pressure from large orders [1] Shareholder Structure - As of November 10, the number of shareholders for Huali Chuangtong was 98,300, a decrease of 1.70% from the previous period, with an average of 5,250 circulating shares per shareholder, an increase of 1.73% [2] - The top ten circulating shareholders include various ETFs, with notable reductions in holdings from several major shareholders [3]

Core Viewpoint - The company has developed multiple chips and modules that support the BeiDou short message function, indicating a strong focus on the BeiDou satellite navigation system [1] Group 1 - The company has introduced the BeiDou III short message RF baseband integrated SoC chip (HBD2023), which is characterized by its small size, low power consumption, and high integration [1] - The HBD2023 chip is designed to meet the needs of various small-scale applications requiring BeiDou short messages and indoor/outdoor positioning [1]

Group 1 - The core point of the article is that the company Huari Chuantong (300045.SZ) has confirmed that its ongoing research and development project, which focuses on radiation-resistant modules for space computing, can potentially contribute to the construction of space computing capabilities [2] Group 2 - The specific project mentioned is titled "Research and Industrialization of Radiation-Resistant Module-Based Space Computing Processing Equipment" [2] - The company engaged with investors on an interactive platform, indicating transparency and willingness to address investor inquiries [2] - The future products and technologies developed from this project are aimed at serving the needs of space computing infrastructure [2]

Core Viewpoint - The company has planned products related to low-orbit satellites and has initiated research and development work [1] Group 1 - The company is actively engaging in the development of low-orbit satellite-related products [1]

证券日报网讯11月18日晚间，华力创通（300045）发布公告称，近日，公司董事会收到独立董事田小兵 先生的通知，获悉其已按照相关规定参加了由深圳证券交易所举办的上市公司独立董事任前培训(线 上)，并取得了由深圳证券交易所创业企业培训中心颁发的《上市公司独立董事培训证明》。 ...

北京华力创通科技股份有限公司 关于独立董事取得独立董事资格证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 截至 2025 年第一次临时股东会通知发出之日，田小兵先生尚未取得独立董 事资格证书。根据深圳证券交易所的有关规定，田小兵先生已书面承诺参加最近 一次独立董事培训并取得深圳证券交易所认可的独立董事资格证书。具体内容详 见公司于 2025 年 10 月 22 日在巨潮资讯网(www.cninfo.com.cn)披露的《关于补 选公司第六届董事会独立董事及调整专门委员会委员的公告》（公告编号： 2025-057）。 近日，公司董事会收到独立董事田小兵先生的通知，获悉其已按照相关规定 参加了由深圳证券交易所举办的上市公司独立董事任前培训(线上)，并取得了由 深圳证券交易所创业企业培训中心颁发的《上市公司独立董事培训证明》。 证券代码：300045 证券简称：华力创通 公告编号：2025-066 北京华力创通科技股份有限公司（以下简称"公司"）于 2025 年 10 月 22 日召开公司第六届董事会第十四次会议和 2025 年 11 月 10 日召开公 ...

Group 1 - On November 17, a total of 12 companies were investigated by institutions, with 6 companies being focused on by funds, including Fuxiang Pharmaceutical, Lingzhi Software, and Fengyuan Co., Ltd. [1] - Fuxiang Pharmaceutical received the most attention, with 12 funds participating in its investigation, while Lingzhi Software and Fengyuan Co., Ltd. had 11 and 5 funds involved, respectively [1][2] - Among the companies investigated, there were 3 from the Shenzhen Main Board, 2 from the ChiNext Board, and 1 from the Sci-Tech Innovation Board [1] Group 2 - In terms of total market capitalization, 2 companies had a market value of less than 10 billion yuan, namely Lingzhi Software and Fengyuan Co., Ltd. [2] - Over the past 5 days, 4 of the investigated stocks increased in value, with Fuxiang Pharmaceutical and Fengyuan Co., Ltd. showing significant gains of 56.90% and 33.24%, respectively [2] - The stocks that experienced declines included Lingzhi Software and Huali Chuantong, with declines of 14.86% and 3.13%, respectively [2][3] Group 3 - The latest closing prices and 5-day price changes for the investigated companies are as follows: Fuxiang Pharmaceutical at 21.15 yuan (+56.90%), Lingzhi Software at 15.13 yuan (-14.86%), Fengyuan Co., Ltd. at 23.85 yuan (+33.24%), and Shiji Information at 10.03 yuan (+7.16%) [3] - The highest net inflow of funds over the past 5 days was seen in Fengyuan Co., Ltd. with 450 million yuan, followed by Guangdong Hongda and Shiji Information with net inflows of 186 million yuan and 94.91 million yuan, respectively [2]

每经AI快讯，华力创通（SZ 300045，收盘价：23.22元）发布公告称，2025年11月17日15:00-16:30，华 力创通接受益民基金调研，公司董事会秘书宋龙参与接待，并回答了投资者提出的问题。 2024年1至12月份，华力创通的营业收入构成为：电子信息产业占比95.56%，轨道交通装备行业占比 4.21%，其他业务占比0.23%。 截至发稿，华力创通市值为154亿元。 每经头条（nbdtoutiao）——段睿：我与蔡磊是 "找钥匙的人"，纵使生前寻不到，也要为其他渐冻症患 者铺就近路 （记者 曾健辉） ...

证券代码：300045 证券简称：华力创通 北京华力创通科技股份有限公司 投资者关系活动记录表 答：您好，公司高度重视低轨卫星领域的发展机遇，长 期跟踪行业发展趋势与市场动态。前期曾参与国内低轨通信 卫星有关的通信协议和行业标准的论证，具备一定的行业研 究和技术储备。目前公司聚焦低轨卫星领域关键产品的研发， 正在推进的研发项目：一是"基于抗辐照模组的星载计算处 理设备研制及产业化项目"，自主研发面向低轨卫星的具备 抗辐照性能的低成本模组以及星载计算处理设备；二是"多 模卫星通信 SOC 芯片研制及产业化项目"，重点研发高低轨 融合卫星通信芯片。上述项目不仅能丰富公司产品矩阵、强 化技术壁垒，同时有助于国内低轨卫星星座的建设，为卫星 互联终端产品提供无缝覆盖的全球通信服务。后续，公司将 持续深化技术迭代与产品落地，积极拓展与低轨卫星领域头 部企业的合作机会，助力我国低轨卫星产业自主可控与规模 化发展。 4、星载设备的价值量情况及相关时间推进节奏是什么？ 答：您好，当前商业航天进入快速发展期，大规模星座 建设对卫星需求较大，为降低卫星制造成本以及提高卫星寿 命，公司重点推进星上抗辐照器件研制及生产，并具备批量 供 ...

证券日报网讯华力创通（300045）11月17日在互动平台回答投资者提问时表示，截至2025年11月10日， 公司的股东户数为98328户。 ...